Oncopharmpod
Niraparib + Abiraterone, Elranatamab, & Melphalan Updates
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:25
- Mas informaciones
Informações:
Sinopsis
A combination product is now available of niraparib + abiraterone for use in mCRPC. Another BCMA-CD3 agent is approved for r/r multiple myeloma and melphalan hepatic arterial infusion for metastatic uveal melanoma is approved.
